Vericel Corporation (VCEL) Social Stream
VERICEL CORP (VCEL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering VCEL.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 5 | $68.001 | $62 | $65.65 | $34.09 | 92.58% |
| 2021-12-01 | 5 | $68 | $54 | $60.75 | $34.09 | 78.2% |
| 2022-01-12 | 5 | $68 | $52 | $60.15 | $34.09 | 76.44% |
| 2022-01-18 | 5 | $68 | $52 | $57.75 | $34.09 | 69.4% |
| 2022-01-24 | 5 | $68 | $40 | $54.95 | $34.09 | 61.19% |
| 2022-02-01 | 5 | $61.75 | $40 | $51.95 | $34.09 | 52.39% |
| 2022-02-25 | 5 | $55.6 | $40 | $50.72 | $34.09 | 48.78% |
| 2022-05-04 | 5 | $55.6 | $44 | $50.12 | $34.09 | 47.02% |
| 2022-05-05 | 5 | $53 | $45 | $50.6 | $34.09 | 48.43% |
| 2022-06-06 | 4 | $53 | $36 | $48 | $34.09 | 40.8% |
| 2022-07-18 | 5 | $53 | $34 | $45.2 | $34.09 | 32.59% |
| 2022-08-04 | 5 | $53 | $34 | $45.6 | $34.09 | 33.76% |
| 2022-11-01 | 5 | $53 | $34 | $43 | $34.09 | 26.14% |
| 2022-11-10 | 5 | $45 | $22 | $35.2 | $34.09 | 3.26% |
| 2022-12-01 | 5 | $45 | $22 | $33.4 | $34.09 | -2.02% |
| 2022-12-20 | 5 | $45 | $25 | $34 | $34.09 | -0.26% |
| 2023-01-03 | 5 | $45 | $25 | $34.4 | $34.09 | 0.91% |
| 2023-01-27 | 5 | $44 | $25 | $34.2 | $34.09 | 0.32% |
| 2023-01-31 | 5 | $44 | $29 | $35 | $34.09 | 2.67% |
| 2023-02-02 | 5 | $44 | $29 | $36 | $34.09 | 5.6% |
| 2023-02-28 | 5 | $44 | $31 | $36.4 | $34.09 | 6.78% |
| 2023-03-01 | 5 | $44 | $31 | $37 | $34.09 | 8.54% |
| 2023-05-11 | 5 | $44 | $34 | $38.6 | $34.09 | 13.23% |
| 2023-06-01 | 5 | $42 | $34 | $38.2 | $34.09 | 12.06% |
| 2023-07-19 | 5 | $42 | $37 | $40.75 | $34.09 | 19.54% |
| 2023-08-03 | 5 | $42 | $39 | $41 | $34.09 | 20.27% |
| 2023-08-08 | 5 | $42 | $39 | $40.6 | $34.09 | 19.1% |
| 2023-09-01 | 5 | $44 | $39 | $41 | $34.09 | 20.27% |
| 2023-09-21 | 5 | $44.5 | $39 | $41.7 | $34.09 | 22.32% |
The Trend in the Analyst Price Target
VCEL's average price target has moved up $6.5 over the prior 45 weeks.
Over the past 49 weeks, VCEL's average upside potential has been 29.6%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-01 | 5 | 45 | 22 | 33.40 | 23.05 | 44.9% |
| 2023-01-03 | 5 | 45 | 25 | 34.40 | 25.13 | 36.89% |
| 2023-01-27 | 5 | 44 | 25 | 34.20 | 28.53 | 19.87% |
| 2023-02-27 | 5 | 44 | 31 | 36.40 | 30.69 | 18.61% |
| 2023-07-19 | 5 | 42 | 37 | 40.75 | 39.25 | 3.82% |
VCEL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.4 | 4 | 0 | 1 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
VCEL's average broker recommendation rating worsened by 0.4 over the prior 48 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, VERICEL CORP's number of analysts covering the stock is higher than 697.13% of them.
- In the context of Pharmaceutical Products stocks, VERICEL CORP's upside potential (average analyst target price relative to current price) is higher than 623.85% of them.
- VERICEL CORP's variance in analysts' estimates is lower than -624.34% of Pharmaceutical Products stocks.
- VERICEL CORP's average analyst price target is higher than 2136.75% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to VERICEL CORP are BCRX, ENZN, and IMCR.
View All Top Stocks by Price Target
Is VCEL a Buy, Hold or Sell? See the POWR Ratings now!